Hematologic Cancers

Tiffany Richards provides an overview of the most common questions she hears from patients regarding daratumumab.

Tiffany Richards expresses her positive outlook on daratumumab, citing that the treatment has helped extend life expentancies.

Tiffany Richards explains the difficulties she has encountered in managing patients who have battled myeloma for an extended period of time and have experienced multiple relapses.

Tiffany Richards identifies the many recources she leverages to stay current on new treatments.

Leslie Lauersdorf hopes that multiple myeloma can eventually become a chronic disease, if not cured completely, so that patients with the disease can live life uninterrupted.

Leslie Lauersdorf is excited by the prospect of new mutliple myeloma therapies, and notes that finding the best sequence for each patient is key.

Leslie Lauersdorf notes that having patients assist in managing their own side effects is important to help them stay on treatment and improve their quality of life.

Leslie Lauersdorf believes patient education is important in both newly diagnosed pateints with multiple myeloma or patients with relapsed/refractory disease to help them understand their disease and the different treatment options.

Beth Faiman discusses the difficulty of keeping abreast of all the new multiple myeloma treatments and how she personally stays up to date on all of the information.

Leslie Lauersdorf discusses the need to balance optimism and realism in caring for patients with relapsed/refractory multiple myeloma.